Skip to main content
. Author manuscript; available in PMC: 2017 Jul 17.
Published in final edited form as: Patient. 2016 Apr;9(2):149–159. doi: 10.1007/s40271-015-0134-z

Table 5.

Adjusted* mean attribute importance scores, overall, and by whether participant rated dominant scenario highest

Attributes Attribute importance overall Mean(SE)**
Five-year risk of breast cancer 16.8(0.61)
Time needed to take the pill for it to work 16.8(0.66)
Risk of endometrial cancer 12.4(0.61)
Risk of blood clots 12.1(0.58)
Reduction in risk of breast cancer 11.5(0.54)
Risk of hormone symptoms 10.4(0.46)
Is there a blood test to tell if pill is working 10.3(0.55)
Reduction in risk of bone fractures 9.6(0.46)
*

Adjusted for age, race, Hispanic ethnicity, education, and family history of breast cancer

**

R2 for all models <0.10